MCL1 and Miyoshi myopathy: Although it has been reported that Bcl-2, a protein with a relatively long half-life [34] may also represent an important survival factor for MM cells [35], pharmacologic or genetic disruption of the P-TEFb apparatus killed MM cells without down-regulating this protein, arguing that reductions in Mcl-1 played a primary role in this setting.